BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Jan. 9, 2008
View Archived Issues
Addex, Merck Ink $702M Deal for Schizophrenia Compound
Merck & Co. Inc. demonstrated its liking for Addex Pharmaceuticals AG's approach to modulating glutamate receptors by entering a second deal with the Swiss firm in consecutive months. (BioWorld International)
Read More
NicOx Renews Research Deal with Pfizer in Ophthalmology
Read More
Gene Variant Could Provide Clues to the Cause of ALS
Read More
Silence Tries to Calm Investors After Share Price Takes a Dive
Read More
EMA Promises to Boost Professionalism in 2008
Read More
Faust Signs Research Deal with Takeda for GPCRs
Read More
Sepracor Enters $175M Deal with Bial for Epilepsy Drug
Read More
Biotech Industry Welcomes EU Support for its Products
Read More
Other News To Note
Read More
Financings Roundup
Read More